BMI1 and hepatocellular carcinoma: Multiple studies have reported that BMI1 controls hematopoietic stem cell (HSC) self-renewal, induces epithelial cell proliferation and modulates malignant behaviours in various types of cancers, including hepatocellular carcinoma (HCC) via Wnt/β-catenin pathway [30,31,32].